Twist Bioscience Corp

CRISPR Therapeutics

Recursion Pharmaceuticals

CareDx

Adaptive Biotechnologies

Veracyte

Ionis Pharma

Nurix Therapeutics, Inc

Beam Therapeutics

Intellia Therapeutics

ARK Genomic Revolution Multi-Sector ETF

ARKG is an actively managed fund that targets companies involved in the genomics industry.

ARK Innovation ETF

Some of the best performing ETFs in 2020 have been the Ark Funds, actively managed ETFs led by Cathie Wood. A long-time Tesla Inc (NASDAQ: TSLA) and technology stock bull, Wood is now betting heavily on genomic stocks.

Are Genomic Stocks Are The Next FANG Stocks?

ARK Fintech Innovation ETF

ARK Web x.0 ETF

SoFi Gig Economy ETF

The year 2020 has been beneficial for equities despite coronavirus outbreak. These active ETFs, however, breezed past the benchmark index.

6 Best Active ETFs of 2020

A biotechnology exchange traded fund focusing on CRISPR gene editing bucked the broader market trends on Monday. Among the best performing non-leveraged ETFs of Monday, the ARK Genomic Revolution Multi-Sector Fund (CBOE: ARKG) advanced 7.1%.

Biotech ETFs Tracking CRISPR Gene Editing Surge

Invesco WilderHill Clean Energy ETF

Invesco Solar ETF

The best ETFs for Q1 2021 are ARKG, TAN, and PBW.

Best ETFs for Q1 2021

The ARK Genomic Revolution Multi-Sector Fund (CBOE: ARKG) doesn't need more catalysts, but in the rapidly evolving genomics spaces they keep on coming. ARKG is a substantial departure from the health care ETF most investors are accustomed to.

The ARKG ETF Doesn't Need More Catalysts. It's Getting Them Anyway

Tech stocks have already led the stock market to several record highs in 2020. JPMorgan thinks investors want to double down on the sector. The bank is letting investors in on a new trade that amplifies bets on three tech-focused exchange-traded funds, Bloomberg reported Monday. The product tracks three ETFs from Ark Investment Management leveraged 1.5 times over a six-year period. JPMorgan has already sold $589,000 of the notes.

JPMorgan rolls out a supercharged tech trade designed to amplify gains in stocks like Tesla, report says

Amplify Online Retail ETF

Renaissance IPO ETF

Global X Lithium & Battery Tech ETF

We have presented a bunch of top-performing ETFs from various corners of the market that gained in triple digits from a year-to-date look and will likely continue outperforming, should the trends prevail.

8 ETFs That Have Gained More Than 100% in 2020

One of the most compelling elements in the genomics investment thesis is that costs are declining, making the next generation of healthcare solutions more accessible. That trend also benefits financial assets, such as the ARK Genomic Revolution Multi-Sector Fund (CBOE: ARKG).

Falling Costs Make Genomics (and Their ETFs) More Attractive than Ever

ARK Industrial Innovation ETF

5 Of My Favorite ARK Positions

Beam Global

EHang Holdings Ltd - ADR

Ford Motor Company

Gigcapital2

Luminar Technologies

Li Auto Inc.

Oaktree Acquisition Corp

QuantumScape

Toyota Motor

Tesla

Volkswagen AG

XPeng

Listen in to hear how you can profit in 2021 and beyond

MoneyLine Podcast: These Stocks are Making MASSIVE Moves

InfraCap MLP

Global X Copper Miners ETF

Amplify Treatments Testing & Advancements ETF

iShares U.S. Oil Equipment & Services ETF

AdvisorShares Pure US Cannabis ETF

Global X Cannabis ETF

The S&P 500, the Dow Jones and the Nasdaq Composite -- all three indexes touched all-time closing highs to end last week.

Top Sector ETFs of Record-Setting Last Week

ARKG aims to capitalize on a $9Tn TAM with the convergence of AI, DNA Sequencing and Gene-Editing. ARKG is up 149% YTD vs. the SPX return of 13%.

ARKG: Perennial Outperformance Ahead

Healthcare is often viewed as a defensive sector, but it's evolving, offering investors more credible avenues for growth. One of the prime avenues for tapping into that trend is the ARK Genomic Revolution Multi-Sector Fund (CBOE: ARKG).

Up 144% in a Tumultuous 2020? No Surprise for ARKG

Precision medicine is in its nascent stages, but the field is rapidly growing, adding another catalyst to an already lengthy list for the ARK Genomic Revolution Multi-Sector Fund (CBOE: ARKG). One of the driving forces behind ARKG's enviable long-term track records is its the manager's ability to identify disruptive forces in the healthcare and genomics [.

How Precision Medicine Will Revolutionize Healthcare

We have highlighted five ETFs from different zones that have been star performers so far this year and deserve special thanks and attention going into the New Year.

5 ETFs Deserving Special Thanks in Pandemic-Stricken 2020

Longview Acquisition Corp.

A prominent fund manager has initiated a position in the special purpose acquisition company.

Why Longview Acquisition Stock Popped Today

Investors seeking big-time growth potential, thematic exposure, and active management themes may want to give the ARK Genomic Revolution Multi-Sector Fund (CBOE: ARKG) serious consideration. ARKG includes companies that merge healthcare with technology to capitalize on the revolution in genomic sequencing.

The Genomics ETF on the Front Lines of Cancer Detection

KraneShares MSCI All China Health Care Index ETF

Invesco DWA Healthcare Momentum ETF

The best healthcare ETFs for Q1 2021 are ARKG, PTH, and KURE.

Best Healthcare ETFs for Q1 2021

It's been a sensational year for an ETF active manager known for contrarian conviction.

Ark ETFs Defying Gravity

Principal Healthcare Innovators Index ETF

iShares Genomics Immunology and Healthcare ETF

The best biotech ETFs for Q1 2021 are ARKG, BTEC, and IDNA.

Best Biotech ETFs for Q1 2021

Teladoc

The Ark ETFs from Catherine Wood are among the best performing ETFs in 2020 and the active trading could help investors follow potential winning ideas. What Happened: Wood added additional shares in Teladoc Health (NYSE: TDOC) last week as the stock declined 9% over the last five days.

Cathie Wood Increases Teladoc Holdings Across Ark ETFs

There are multiple exchange traded funds addressing the lucrative genomics segment, but the real star of the group is the ARK Genomic Revolution Multi-Sector Fund (CBOE: ARKG). ARKG includes companies that merge healthcare with technology to capitalize on the revolution in genomic sequencing.

Inside a Star Genomics ETF's Notoriety

VanEck Vectors Biotech ETF

First Trust NYSE Arca Biotechnology Index Fund

SPDR S&P Biotech ETF

As coronavirus cases start to tick upwards once more, the race to create a vaccine will only intensify, boding well for the biotechnology sector. ETF investors may want to keep an eye on biotech funds, which are already garnering interest as 2020 winds down.

Can't Get Enough Biotech Exposure in Your Portfolio?

ARK Genomic Revolution Multi-Sector ETF captures innovation in an industry that is severely under-covered relative to other ARK focused industries. Existing treatments for severe diseases are very expensive and slow to develop and are not very effective.

The Most Underrated ARK ETF Is ARK Genomic Revolution Multi-Sector ETF

There are some investment niches where active management can benefit investors and biotechnology. Genomics is one such industry and the ARK Genomic Revolution Multi-Sector Fund (CBOE: ARKG) stands out as a prime example.

News for ARK Genomic Revolution Multi-Sector ETF ETF (ARKG)